A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Clinical trial NCT01886053 · COMPLETED

Trial details

NCT number: NCT01886053
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Community Acquired Pneumonia

Start date: 2011-04-01
Primary completion: 2012-07-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.